Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News Archive
News Archive Navigation
News Archive Navigation Language
November 2021
-
The art of drug design in a technological age
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.
-
Stopping this coronavirus – and the next one
Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.
-
Solving the puzzle of immunotherapy
From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.
-
Breaking down barriers for patients with sickle cell disease
One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.
-
To make a difference, start with patients
John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.
October 2021
-
Demystifying the science of myelodysplastic syndromes
Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.
-
Restoring vision and hope to thousands in Southeast Asia
Eyesight initiatives are restoring vision – and hope – to thousands of people in Southeast Asia by expanding equitable access to eye care.
-
Expanding a new digital healthcare solution across chronic heart disease management
More than 100,000 patients with heart failure in China are using our new AI-enabled platform, AI Nurse, to manage their condition and aim for better health.
September 2021
-
Photographer Captures Patients Around the World Persevering With ITP
To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.
-
Toward regrowing cartilage
Novartis researchers aim to improve the lives of patients with osteoarthritis.
-
Doing the right thing is good business
Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.
-
A blood cancer patient’s long road to diagnosis
Ilona, a patient living with polycythemia vera, shares her experiences with this rare blood cancer
Pagination
- ‹ Previous page
- 1
- …
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- …
- 32
- › Next page